GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Additional Paid-In Capital

Diasorin SpA (LTS:0GZX) Additional Paid-In Capital : €0 Mil(As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Additional Paid-In Capital?


Diasorin SpA's quarterly additional paid-in capital increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€18 Mil) but then stayed the same from Dec. 2023 (€18 Mil) to Mar. 2024 (€0 Mil).

Diasorin SpA's annual additional paid-in capital stayed the same from Dec. 2021 (€18 Mil) to Dec. 2022 (€18 Mil) and stayed the same from Dec. 2022 (€18 Mil) to Dec. 2023 (€18 Mil).

Diasorin SpA Additional Paid-In Capital Historical Data

The historical data trend for Diasorin SpA's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Additional Paid-In Capital Chart

Diasorin SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.16 18.16 18.16 18.16 18.16

Diasorin SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 18.16 -

Diasorin SpA Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Diasorin SpA Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA (LTS:0GZX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (LTS:0GZX) » Definitions » Additional Paid-In Capital
Comparable Companies
HKSE:00712 HKSE:08609 HKSE:08070 HKSE:01527 HKSE:01933 HKSE:08160 HKSE:00380 HKSE:01749 HKSE:01273 HKSE:00483 TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN
Traded in Other Exchanges
DSRLF:USA DIA:Italy 34D:Germany
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Website
https://www.diasoringroup.com
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.

Diasorin SpA (LTS:0GZX) Headlines

No Headlines